Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
Tanya Siddiqi, Sandra H Thomas, Robert Chen City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA Abstract: Brentuximab vedotin (BV) is an antibody-drug conjugate that targets CD30-positive malignancies via an anti-CD30 monoclonal antibody linked to monomethy...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Libro |
| Publicado: |
Dove Medical Press,
2014-02-01T00:00:00Z.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Disponible |